Portfolio company
Strand Tx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Strand Tx develops programmable messenger RNA therapeutics for patients with cancer and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Strand Therapeutics
This biotechnology company develops programmable messenger RNA therapies for patients with solid tumours and autoimmune diseases.
Synthetic biology-powered mRNA therapeutics
The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.
Kernal Bio
Kernal Bio develops selective messenger RNA therapeutics for patients with cancer and autoimmune diseases to enable precise in vivo cell programming.
Typewriter Therapeutics
The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.
Shape Therapeutics
The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.
Noara Therapeutics
This company engineers stable and immunosilent ribonucleic acid therapies using machine intelligence to treat patients with chronic and complex diseases.
Orna Therapeutics
This company develops engineered circular RNA therapies and delivery systems to treat patients with cancer, autoimmune conditions, and genetic diseases.
Capstan Therapeutics
Capstan Therapeutics develops in vivo RNA-based therapies for patients with autoimmune diseases and cancers using targeted lipid nanoparticle technology.